A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Placebo in Acute Bronchitis Patients

Clinical trial NCT03309800 · COMPLETED

Trial details

NCT number: NCT03309800
Sponsor: Hanlim Pharm. Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Bronchitis

Start date: 2017-03-29
Primary completion: 2017-08-17
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.